PMV Pharmaceuticals, Inc. (PMVP) DCF Valuation

PMV Pharmaceuticals, Inc. (PMVP) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
PMV Pharmaceuticals, Inc. (PMVP) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

PMV Pharmaceuticals, Inc. (PMVP) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial future of PMV Pharmaceuticals, Inc. (PMVP) with our user-friendly DCF Calculator! Just enter your assumptions for growth, margins, and costs to calculate the intrinsic value of PMV Pharmaceuticals, Inc. (PMVP) and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -26.2 -34.6 -58.0 -76.7 -78.9 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .4 .3 1.3 .7 1.3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -26.6 -34.9 -59.3 -77.4 -80.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 101.5 361.4 297.2 241.1 203.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.8 1.6 3.2 3.0 3.2 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.1 -1.3 -8.0 -1.0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -0.00290032 -0.00290032 -0.00290032 -0.00290032 -0.00290032 -0.00290032 -0.00290032 -0.00290032 -0.00290032 -0.00290032
EBITAT -26.6 -34.9 -59.3 -77.4 -80.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -23.5 -36.0 -57.8 -84.9 -79.6 -3.2 .0 .0 .0 .0
WACC, % 10.36 10.36 10.36 10.36 10.36 10.36 10.36 10.36 10.36 10.36
PV UFCF
SUM PV UFCF -2.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt -24
Equity Value 21
Diluted Shares Outstanding, MM 48
Equity Value Per Share 0.45

What You Will Get

  • Real PMV Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for PMV Pharmaceuticals, Inc. (PMVP).
  • Full Customization: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
  • Instant Valuation Updates: Automatic recalculations to assess the impact of changes on PMV Pharmaceuticals, Inc.'s (PMVP) fair value.
  • Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections specific to PMV Pharmaceuticals, Inc. (PMVP).
  • Time-Saving and Accurate: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Comprehensive Data: PMV Pharmaceuticals, Inc.'s historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Observe PMV Pharmaceuticals' intrinsic value recalculating instantly.
  • Visual Dashboard: Charts that clearly present valuation results and essential metrics.
  • Designed for Precision: A reliable tool for analysts, investors, and finance professionals.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring PMV Pharmaceuticals, Inc. (PMVP)'s preloaded data.
  • 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results Instantly: The DCF model automatically calculates intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to back your strategic decisions.

Why Choose This Calculator for PMV Pharmaceuticals, Inc. (PMVP)?

  • User-Friendly Interface: Tailored for both novice and seasoned users.
  • Customizable Inputs: Adjust parameters easily to align with your financial analysis.
  • Real-Time Adjustments: Watch PMV Pharmaceuticals' valuation update instantly as you change inputs.
  • Pre-Loaded Data: Comes equipped with PMV Pharmaceuticals' latest financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making strategic decisions.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing PMV Pharmaceuticals, Inc. (PMVP).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in PMV Pharmaceuticals, Inc. (PMVP).
  • Students and Educators: Leverage real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like PMV Pharmaceuticals, Inc. (PMVP) are valued in the investment landscape.

What the Template Contains

  • Pre-Filled DCF Model: PMV Pharmaceuticals’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate PMV Pharmaceuticals’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

Es wurden keine passenden Produkte gefunden.